[1] Wang QB,Zhu H,Liu HL,et al. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis:A meta-analysis.Hepatology,2012,56(1):239-247. [2] Motosugi U,Ichikawa T,Oguri M,et al. Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging:comparison with aspartate aminotransferase-to-platelet ratio index. Magn Reson Imaging,2011,29(8):1047-1052. [3] Martínez SM,Crespo G,Navasa M,et al. Noninvasive assessment of liver fibrosis. Hepatology,2011,53(1):325-335. [4] Sandrasegaran K,Akisik FM,Lin C,et al. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR,2009,193(6):1556-1560. [5] Nishie A,Asayama Y,Ishigami K,et al. MR prediction of liver fibrosis using a liver-specific contrast agent:Superparamagnetic iron oxide versus Gd-EOB-DTPA. J Magn Reson Imaging,2012,36(3):664-671. [6] 柴维敏,严福华,王鹤,等. 体素内不规则运动磁共振成像在肝纤维化评估中的初步应用.诊断学理论与实践,2014,13(1):77-81. [7] 曾民德,陆伦根,茅益民.肝纤维化的诊断方法及其评估(上).肝脏,2006,11(2):102-105. [8] 彭婕,冯菲,潘桂霞,等.不同浓度四氯化碳诱导兔肝纤维化模型的对照研究.成都医学院学报,2012,7(1):32-36. [9] 陈宝祥,曹海利,郭若涵,等. 家兔肝纤维化模型四氯化碳剂量递增法. 中国公共卫生,2014,30(10):1262-1264. [10] 顾广祥,施晓雷,杭化莲,等. 兔慢性肝损害急性肝衰竭动物模型的建立. 中华实验外科杂志,2011,28(5):809-812. [11] Koinuma M,Ohashi I,Hanafusa K,et al. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging,2005,22(1):80-85. [12] Braithwaite AC,Dale BM,Boll DT,et al. Short-and midterm reproducibility of apparent diffusion coefficient measurements at 3.0T diffusion-weighted imaging of the abdomen.Radiology,2009,253(2):459-465. [13] Watanabe H,Kanematsu M,Goshima S,et al. Staging hepatic fibrosis:comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging-preliminary observations. Radiology,2011,259(1):142-150. [14] 范国华,龚建平,沈钧康,等. MR扩散加权成像在大鼠肝纤维化诊断中的价值.中华放射学杂志,2013,47(2):172-177. [15] Zhou IY,Gao DS,Chow AM,et al. Effect of diffusion time on liver DWI:an experimental study of normal and fibrotic livers. Magn Reson Med,2014,72(5):1389-1396. [16] 崔恩铭,龙晚生,罗学毛,等. 多b值弥散加权成像评估肝纤维化程度. 中国医学影像技术,2013,29(10):1678-1682. [17] Lewin M,Poujol-Robea A,Boelle PY,et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.Hepatology,2007,46(3):658-665. [18] 石喻,郭启勇,富西湖,等. 3.0TMR标准化表观扩散系数值评价肝纤维化程度的研究. 中华放射学杂志,2012,46(4):322-326. [19] Taouli B,Koh DM. Diffusion-weighted MR imaging of the liver. Radiology,2010,254(1):47-66. [20] 郭秋,任克,徐克,等肝纤维化ADC值减低机制及与选取b值关系的实验研究. 中国医学影像技术,2011,27(9):1756-1760. [21] 张馨,汪茂荣,马勇,等. 慢性乙型肝炎患者肝组织PDGF表达与肝窦病变的关系. 实用肝脏病杂志,2012,15(1):1-3. |